Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, InMed Pharmaceuticals Inc increased its cash reserves by 44.29%, or 2.74m. Cash Flow from Financing totalled 10.68m or 258.26% of revenues. In addition the company used 7.28m for operations while cash used for investing totalled 661.80k.
Cash flow per share | -0.9667 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 1.75 |
---|---|
Tangible book value per share | 1.46 |
More ▼
Balance sheet in USDView more
Current ratio | 6.58 |
---|---|
Quick ratio | 5.80 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼